Search results

Page title matches

• New drug application
  ...nt for those specific conditions. Prior to the NDA, the '''Investigational New Drug Application (IND)''' effectively approves the use of the drug in specific [[randomized
  5 KB (808 words) - 15:51, 30 August 2009
• New Drug Application
  #REDIRECT [[New drug application]]
  34 bytes (4 words) - 20:31, 14 October 2008
• New drug application/Definition
  298 bytes (42 words) - 14:43, 4 October 2008
• New drug application/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/New drug application]]. Needs checking by a human.
  525 bytes (67 words) - 18:59, 11 January 2010

Page text matches

• New Drug Application
  #REDIRECT [[New drug application]]
  34 bytes (4 words) - 20:31, 14 October 2008
• Alfuzosin
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  1 KB (142 words) - 11:47, 2 February 2023
• Tamsulosin
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  1 KB (142 words) - 14:35, 2 February 2023
• Bupropion
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1999.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  1 KB (163 words) - 14:10, 9 October 2009
• Omeprazole
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2008.<ref>{{FDA-Drug_Details|075347}}</ref> In 4/2008, a delayed
  2 KB (199 words) - 14:07, 2 February 2023
• Rosuvastatin
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2011.<ref>{{FDA-Drug_Details|202172}}</ref>
  2 KB (265 words) - 14:07, 2 February 2023
• New drug application/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/New drug application]]. Needs checking by a human.
  525 bytes (67 words) - 18:59, 11 January 2010
• Adderall
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  3 KB (410 words) - 11:51, 2 February 2023
• Tenofovir
  ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2001.<ref>{{FDA-Drug_Details|021356}}</ref> ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>{{FDA-Drug_Details|078800}}</ref> The generic ANDA was
  2 KB (335 words) - 14:35, 2 February 2023
• Finasteride
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 200_.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  3 KB (403 words) - 13:22, 2 February 2023
• Zidovudine
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1995.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  3 KB (394 words) - 07:05, 17 October 2009
• Valacyclovir
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  4 KB (502 words) - 14:34, 2 February 2023
• New drug application
  ...nt for those specific conditions. Prior to the NDA, the '''Investigational New Drug Application (IND)''' effectively approves the use of the drug in specific [[randomized
  5 KB (808 words) - 15:51, 30 August 2009
• Buprenorphine
  ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/ ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 1996.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  6 KB (820 words) - 11:49, 2 February 2023
• Defibrillator/Related Articles
  {{r|New drug application}}
  630 bytes (80 words) - 15:53, 11 January 2010
• Carboplatin
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  4 KB (489 words) - 08:06, 27 June 2010
• Thiazolidinedione
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2004.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2005.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda
  6 KB (804 words) - 14:35, 2 February 2023
• Mirtazapine
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2004.<ref>{{FDA-Drug_Details|076119}}</ref>
  3 KB (422 words) - 14:08, 2 February 2023
• Eplerenone
  ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) on July 30, 2008 (Apotex)<ref>{{FDA-Drug_Details|078482}}</ref> and
  3 KB (447 words) - 13:22, 2 February 2023
• Fidaxomicin
  ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2011.<ref>{{FDA-Drug_Details|201699}}</ref>
  2 KB (243 words) - 13:18, 2 February 2023